Annual Stockholders Meeting January 26, 2009

Transcription

1 Annual Stockholders Meeting January 26,

2 Agenda Welcome Chairman s Comments Business Meeting Business Highlights Medical Imaging Systems B-K Ultrasound Anrad Security Technology Going Forward Questions and Answers Jim Green, President & CEO Ed Voboril, Chairman of the Board John Fry, Vice President, General Counsel & Corp. Secretary Jim Green, President & CEO Peter Howard, Sr. Vice President & GM, OEM Medical Group Michael Brock, President, B-K Medical Mervat Faltas, President, Anrad Peter Cempellin, Vice President & GM, Security Systems Jim Green, President & CEO Jim Green, et. al. Refreshments Product Demonstrations Tours Security Technical Leaders Peter Cempellin, Vice President & GM, Security Systems 2 2

3 Ed Voboril Chairman of the Board 3

4 John Fry Vice President, General Counsel, & Corporation Secretary Formal Business Meeting 4

5 Safe Harbor Statement Any statements about future expectations, plans, and prospects for the Company, including statements containing the words believes, anticipates, plans, expects, and similar expressions, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including risks relating to product development and commercialization, limited demand for the Company s products, risks associated with competition, uncertainties associated with regulatory agency approvals, competitive pricing pressures, downturns in the economy, the risk of potential intellectual property litigation, and other factors discussed in our most recent quarterly report filed with the Securities and Exchange Commission. In addition, the forward-looking statements included in this presentation represent the Company s views as of the date of this document. While the Company anticipates that subsequent events and developments will cause the Company s views to change, the Company specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing the Company s views as of any later date. 5 2

6 Jim Green President & CEO 6

7 Our Vision Analogic is a growth-oriented high technology imaging and signal processing Company, focused on engineering excellence, providing products and services to OEMs and end users in high growth medical diagnostics and security markets, dedicated to profitable revenue growth through a combination of organic and acquired opportunities. 7

8 FY 2008: Improvements Across the Board Consolidated revenue of $413.5M, up 21% Income from Operations was $24.3M, up $22M Non-GAAP Income from Ops was $36.9M, up $20M EPS was $1.77 (GAAP) and $2.26 (Non-GAAP), up 61% and 41%, respectively Revenue (Million) $450 $400 $350 $300 $250 $200 $150 $100 $30.0 $25.0 $20.0 $15.0 $10.0 $5.0 $- Income (Loss) from Ops (Million) Turned-around Anrad and Security Businesses Accelerated growth in Medical & Security $50 $ WW Revenues Income (Loss) from Ops $(5.0) $(10.0) Invested in technology Invested in our channel 8

9 Global Presence More than 35 years of innovation in signal and image processing Montreal, Canada Direct, Digital, Selenium Flatpanel X-ray Detectors for Mammography Copenhagen, Denmark Specialized Ultrasound Scanners for Urology and Surgery State College, PA Leading Developer of Ultrasound Probes and Transducers for Medical OEMs Peabody, MA Worldwide Headquarters Engineering and Manufacturing of Medical Imaging Subsystems and Aviation Security Canton, MA Gradient Amplifiers for MRI, and Precision Motion Control Systems Shanghai, China Serving the Needs of Our Customers in China 9

10 Revenue by Segments Medical Technology 85% Medical Imaging, 56% Digital Radiography, 7% Other, 3% Security Technology, 12% BK Medical, 22% 10

11 Peter Howard Senior Vice President and GM OEM Medical Group 11

12 Delivering Results: 2008 Highlights Year-over-year revenue and profit growth Successful introduction of new products DAS for world s first Whole-Heart / Whole-Brain CT 16-slice DMS subsystem 3T RF amp family Important contract wins 64-slice DMS PowerLink feasibility study Multi-channel RF amplifiers Acquisition and integration of Copley Controls Expanded customer and product base Anchor product to expand MR family Platform for growth in relatively flat market 12

13 13

14 Growth Through Innovating Core MR Components Spectrometer Integrated Digital Synthesis RF Power RF Coil Multi-Channel Multi-nuclear Digital - Water Cooling Receive-Power Integration Gradient Coil Coil Amp Optimization Integrated MR Power Shared Infrastructure Advanced Digital Control Smaller Footprint 14

15 Design Innovation Expands Customer Base Improved Reliability MTBF (Hours) Production Year 15

16 Growth Through Innovation Expanded Market Share RF Gradient Enabling Advances in Medical Imaging Multi-channel OEM Luminary partner Leveraging Engineering Capability Integrated Gradient & RF Amplifiers Industry Leader Product Reliability Life-cycle costs 16

17 Michael Brock Division President BK Medical Ultrasound 17

18 BK Medical FY08 Update Consecutive growth last four years High investment in sales channel Extended coverage in most key markets New website: Information center, demo s, webshop, customer contact, lead generation, extensive product information, full technical documentation High investment in R&D to enable full product coverage and enable expansion into new market segments Major product launches in FY08: 8818 Triplane Prostate Transducer - Explore all parts of prostate in one examination. Only solution in the market. VariSeed 8.0 Brachytherapy has never been easier. Co-marketing with Varian Pro Focus OR Dedicated ultrasound system for the OR. Only solution in the market. HistoScanning Enable targeted biopsies by tissue characterization in prostate 18

19 FY09 Major Product Launches Pro Focus UltraView Evolution of the highly successful Pro Focus family Market leading system in high end UROLOGY and SURGERY BK Medical proprietary IQPAC image improvement technology Full size 19 LCD monitor Sealed keyboard to meet rising cleaning demands Completely new technology inside End-user delivery starting January biplane intraoperative transducer Compact size easy access in tight spaces Ergonomic - freehand biopsies from all angles Excellent image quality Introducing consumables: Sterile single-use biopsy guides Meeting increasingly strict cross contamination regulations from hospitals and clinics Complete business setup, including webshop Direct marketing to huge installed base of BK users 19

20 IQPAC TM : New Heights of Image Quality Abdominal image quality now on par with best in class opening new market opportunities Comprising Angular Compound Imaging and Enhanced Tissue Definition Proprietary BK technology 20

21 Introducing flexfocus Meeting doctors needs for a mobile yet fully featured ultrasound system with full size screen Flexible concept enabling cart, wall or tabletop mounting Targeting office UROLOGY plus being an attractive alternative to almost any laptop system range of new transducers available for target applications IQPAC enabling state of the art image quality for that class of system Setting a new standard for design of ultrasound systems End user delivery from April 2009 marketing starting NOW! 21 5

22 New Market Opportunities IQPAC and revolutionary flexfocus design open opportunities in new market segments Comprehensive and differentiating marketing campaign 22

23 Mervat Faltas Division President OEM Medical: Anrad 23

24 Direct Digital Mammography Analogic s Proprietary Amorphous Selenium Achievements in 2008 Toshiba launched Peruru, using Anrad s SMAM detector Siemens announced at RSNA 2008, the integration of the Anrad Stereotactic biopsy detector More than doubled the number of mammography detectors shipped Profitable for two consecutive quarters Peruru 24

25 Mammography Equipment Market Total Market By Technology Worldwide Mammography Market in Unit Shipments FFDM-DDR 37% Analog 34% FFDM-CR 29% $1,800 $1,600 $1,400 $1,200 $1,000 $800 $600 $400 $200 $0 Worldwide Mammography Market by Technology Revenues ($ millions) $147.9 $139.9 $574.9 $143.7 $149.5 $765.7 $140.9 $158.0 $973.2 $138.9 $164.8 $1,149.5 $137.7 $170.4 $1,287.2 $136.4 $174.6 $1, Source: InMedica 2007 FFDM = Full Field Digital Mammography DDR = Direct Digital Radiography CR = Computed Radiography Analog = film CAGR for Worldwide Market (all technologies) is 14.6% CAGR for FFD-DDR is 19.4% 25

26 Today and the Future Today we offer Detector for screening 20% higher patient throughput Detector for Stereotactic biopsy Accuracy and a superior work flow For The Future Tomosynthesis Ready 3-dimensional image of the breast Enhances the diagnostic capabilities Next Generation LMAM Detector Faster Easier to integrate Green technology Lower material cost & easier to manufacture Detector improvements that will enable and facilitate the early detection of breast cancer 26

27 Peter Cempellin Vice President & GM Security Systems 27

28 Checked Baggage Medium Throughput examiner SX Recently TSA Certified Shipments to TSA Q4 FY 2009 Penetrate Small Airports Worldwide Pursuing Sales in Nine Countries 28

29 29

30 Checked Baggage Ultra-High Throughput examiner XLB TSA Certification Testing Underway TSA Baggage Handling Integration Testing Complete First Airport Installation Portland, Oregon, Fall 2009 (8 Units) 30

31 Checkpoint COBRA Deployment Underway Hyannis Barnstable, MA Manhattan, KS Walla Walla, WA Pullman Moscow, WA Jamestown, NY Waco Madison Cooper, TX Oxnard, CA TSA Dual-Mode COBRA Deploy To CAT 3-4 Airports Qualification Testing Planned Tyndall AFB & TSL 31

32 Jim Green President & CEO 32

33 Commitment to Consistent Profitable Growth OEM Medical Size the business to current conditions; drive overheads down Solidify our business with new product introductions Mine the majors; leverage imaging subsystems across customers Security Organic growth through diversified product line to cover the entire checked and dual-use checkpoint End-User Ultrasound Strengthen direct channel Launch our new product families and introduce new clinical applications Penetrate adjacencies and geographies Develop access to high-growth China market Explore Good Fit Acquisitions 33

34 Moving Forward FY2008 was a year of strong growth in both revenue and earnings The global financial crisis is a challenge for FY2009, primarily in large capital medical equipment New product platforms in Medical and Security position us for share growth We re taking immediate cost actions and accelerating optimization of our global cost structure Our cash position and balance sheet remain strong Our considerable technological strength, the continuing growth of medical imaging procedures, and the opportunities for new baggage screening systems position Analogic for both the short and long term 34

35 Jim Green, et. al. Q & A 35

36 Thank You 36